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Although venous thrombosis most often occurs in the
return circulation of the legs and pelvis, it may also occur
in the veins of several organs and compromise venous
return. Thus, the clinician, in any field will regularly be
confronted with manifestations of venous thrombosis in
particular organs. This review summarizes the patho-
Thrombosis of the Central Vein of the Retina
Central retinal vein occlusion presents as a hemorrhagic
or ischemic retinopathy that causes considerable loss in vi-
sual acuity in about half of the affected patients. It is mostly
seen in patients past middle age, occurs with about the same
frequency in both sexes and is usually unilateral.
Pathogenesis
There is a unique anatomic arrangement in the eye where
the central retinal artery shares the same optic sheath with
the central retinal vein. This sheath is a closed compartment;
any space-occupying lesion within this sheath such as ar-
teriosclerotic changes in the artery would, thus, cause a
compression of the central retinal vein (l,2). As the vein
enters the lamina cribrosa, the intraluminal pressure of this
vessel decreases from a range of 20 mm Hg at the optic
disc to levels ranging from zero in the upright position to
10 mm Hg in the reclining position (I). This arrangement
renders the central vein highly susceptible to collapse. In
addition, a veno vasomotor reflex that regulates the vascular
tone of the central retinal vein inversely to the intraluminal
pressure may lead to vasoconstriction and, thus, to a further
reduction in the vessel lumen in case of an outflow obstruc-
tion (3). These physioanatomic peculiarities predispose the
central retinal vein to thrombus formation, which may es-
sentially result from three types of occlusive mechanisms:
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genesis and the main clinical features of venous throm-
bosis in the central retinal vein, the cerebral veins and
$inuses of the skull, the renal and the portal veins and
the hepatic and mesenteric veins as well as priapism.
The principles of treatment are outlined.
(J Am Coli CardioI1986;8:137B-145B)
external compression with secondary proliferation of the
endothelium, primary thrombus formation through stasis (2)
and primary disorder of the vein (degenerative or inflam-
matory).
External compression. Arteriosclerotic changes of the
central retinal artery may narrow the lumen of the adjacent
vein by external compression, resulting in both slowing of
the bloodstream and turbulence of blood flow. The latter
causes secondary endothelial cell proliferation, which fur-
ther contributes to the obliteration of the vein. Any condition
that leads to stagnation of the retinal circulation, such as
partial or complete occlusion of the central retinal artery,
may then precipitate secondary thrombus formation (2). Oc-
clusion of the central vein of the retina associated with
retinal ischemia has been described as a distinct entity of
retinal vascular occlusion, termed "hemorrhagic retinopa-
thy" (4,5). The prognosis for vision of "hemorrhagic ret-
inopathy" is very grave. Other conditions in which external
compression dominates the pathogenesis of central retinal
vein occlusion include papilledema and optic nerve hem-
orrhages, both leading to increased pressure within the optic
sheath (6); ophthalmopathy, orbital tumors and abscesses
causing retrobulbar external compression are rare conditions
leading to the same result (7). Chronic open angle glaucoma,
by elevating intraocular pressure, may produce a deformity
in the vessel wall and, in that way, can also contribute to
increased resistance to blood flow (7).
Primary thrombus formation. Circulation in the retinal
vein offers high resistance to flow, especially in the crib-
riform layer where the central artery and vein are in close
contact. This high resistance keeps intraocular venous pres-
sure high, which is essential in preventing the veins of the
retina from collapsing under the high intraocular pressure.
This valuable resistance, however, limits the capacity of the
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retinal venous circulation to adapt in cases of increased
blood viscosity, which may explain the clear link that exists
between thrombosis of the central vein of the retina and the
hyperviscosity syndromes. Thrombosis of the central vein
of the retina may occur in this way in cases of blood dys-
crasia (that is, polycythemia vera, leukemia, sickle cell dis-
ease and so on, hypergammaglobulinemia, paraproteinemia,
hyperfibrinogenemia and cryofibrinogenemia (7,8).
Primary disorder of the vein. Apart from changes in
blood coagulation, increased platelet aggregability (9) and
impaired fibrinolysis (10), primary diseases of the vessel
wall may play an important role in the pathogenesis of
central retinal vein thrombosis. These include infectious
vasculitis (for example, syphilis and tuberculosis) as well
as systemic vascular disorders as seen, for instance, in con-
nective tissue diseases (7). Thrombosis of the central vein
of the retina is rarely caused by trauma except in cases of
traumatic arteriovenous fistula at the base of the skull. The
association between thrombosis of the central retinal vein
and chronic lung disease may be explained in different ways,
including increased blood viscosity arising from a raised
hematocrit and from decreased deformability of the eryth-
rocytes as a consequence of hypoxia and acidosis.
Clinical Features
Retinal findings. Thrombosis of the central vein of the
retina leads to an increase in venous resistance with stasis
and eventually to macular edema, which is responsible for
the decline in visual acuity. When thrombosis becomes more
extensive, it causes retinal hemorrhages; microinfarcts of
the retina may develop as a consequence of reduced arterial
flow.
Most often, the first complaint is a sudden decrease in
visual acuity of the afflicted eye, sometimes preceded by
photopsia; a more gradual deterioration of vision is the ex-
ception. The features at examination of the fundus of the
eye depend on the location of the thrombus. Dilations and
sinuosity of the branches of the central vein of the retina
are seen, together with scattered retinal hemorrhages along
these branches, congestion and macular edema.
Prognosis. It is impossible to give any prognosis about
visual acuity. It depends primarily on the extent of the
changes in the macula lutea and the duration of the macular
edema. If the central vein of the retina is itself thrombosed,
the occlusion may lie inside the optic nerve or at the site
where the vein leaves the nerve, but it may also lie in the
cribriform layer or even before it reaches this location. In
the first case, numerous collateral veins are available to
reestablish the venous circulation and recovery of normal
visual acuity is possible. In the second case, only a small
number of collateral veins exist and marked and permanent
reduction in visual acuity follows. Although the less severe
form of thrombosis of the central vein of the retina is seen
more often in young people, complete blindness principally
affects patients older than 60 years of age. The period of
recovery is usually 6 months or longer. After about 2 months
have elapsed, angiofluorography may enable a more exact
prognosis to be given; it will be unfavorable if significant
zones of capillary nonperfusion are seen in the retina. In
these cases, neovascular glaucoma often appears.
Treatment
At the present time, there is no satisfactory treatment for
occlusion of the central vein of the retina. Some ophthal-
mologists prescribe heparin, oral anticoagulants, strepto-
kinase, urokinase, anti-inflammatory agents, dextran, vaso-
dilators, antiaggregating agents or vitamins C and P. It has
not been possible to prove a clearly beneficial effect from
most of these treatments.
Treatment of coexistent medical conditions is required,
but has little effect on the visual outcome. Photocoagulation
has some benefits, preventing and improving rubeosis and
neovascular glaucoma (II). Some authors (12) report fa-
vorable results in restoring vision after treatment with oral
anticoagulants, either alone or in combination with uroki-
nase or, less effective, streptokinase. However, the risk of
complications such as vitreous hemorrhage might restrict its
use (II). In a recent study (13), beneficial effects of intra-
venous prostaglandin h administration on visual acuity have
been reported, but wider experience is needed before exact
assessment of the value of this treatment can be made.
Thrombosis of the Cerebral Veins and the
Venous Sinuses of the Skull
Thrombosis of the intracranial veins is poorly under-
stood, partly because of its rarity, and partly because of the
wide individual variations in both symptoms and clinical
course. The majority of the symptoms are principally a result
of the site and extent of the thrombosis, but also depend on
the speed with which the thrombus forms and on the un-
derlying disease.
There are extensive anastomoses between the intracranial
venous system and the extracranial venous system. The
result of this anatomic peculiarity is that infections of the
face, nose, orbit and tonsils may eventually lead to throm-
bosis of the cavernous sinus. Some diseases of the ear may
lead to thrombophlebitis of the neighboring lateral sinus.
These anastomoses explain the spread of thrombosis, but
also the possibility of shunting to compensate for the cir-
culatory disturbance caused by the thrombosis.
Pathogenesis
In the preantibiotic era, the most common cause of throm-
bophlebitis of a venous sinus was an infective process in a
neighboring territory such as otitis media, mastoiditis and
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abscess in the epipharynx or floor of the mouth. Septic
venous thrombosis may also occur during some generalized
infective disease. Currently, the majority of thromboses in
the cerebral veins and venous sinuses of the dura mater are
no longer of infectious origin. In the neonate, birth trauma
is the major cause, while in the infant, three factors pre-
dispose to thrombosis of the superior longitudinal sinus: I)
dehydration from vomiting and diarrhea, 2) generalized in-
fection with septicemia, and 3) cardiac anomalies. During
pregnancy and after delivery. thrombosis of the intracranial
veins and venous sinuses may also appear; as predisposing
factors. low blood pressure and vagotonia should be men-
tioned. An increase in blood coagulability also plays a part
in the process. This explains why the same pathologic pro-
cess may arise in women taking oral contraceptives (14) or
patients who are dehydrated, cachetic or suffering from
polycythemia or hemolysis (15). In cases of heart failure,
it is the high venous pressure that may give rise to throm-
bosis of the venous sinuses in the skull. An expanding
intracerebral process may also involve a cerebral vein. Other
associated disorders are ulcerative colitis (16) and diabetes
mellitus. Thrombosis of intracranial venous sinuses has been
noted more than once during or after peripheral thrombo-
phlebitis. This observation reinforces the hypothesis that so-
called idiopathic thrombosis of intracranial venous sinuses
appears to be a result of the still poorly defined hypercoa-
gulable state.
Thrombosis of the superior longitudinal sinus with or
without involvement of the lateral sinus occurs in the ma-
jority of the cases mentioned. One specific anatomic pe-
culiarity may be responsible for this preferential localiza-
tion, namely, the longitudinal sinus is traversed by many
trabeculae and is sometimes divided into two over a limited
part of its length by a continuous membrane.
After thrombosis of a venous sinus in the dura mater, it
is not uncommon for cerebral infarcts, often hemorrhagic,
to be found at autopsy. These usually involve territories
drained by those cortical veins that end in the obstructed
sinus. There is also fairly well marked cerebral edema as-
sociated with an increase in intracranial pressure.
Clinical Symptoms
Clinical symptoms of thrombosis of an intracranial ve-
nous sinus range from generalized headache with nausea
and vomiting, probably due to raised intracranial pressure,
to sudden epileptic fits or features of local cerebral damage,
or both. The latter are probably the result of thrombosis of
cortical veins and perhaps of hemorrhagic infarcts.
Thrombosis of the superior longitudinal sinus. Acute
thrombosis often begins with focal motor seizures, some-
times extending to the whole of one side of the body and
finally to the opposite side. The focal attacks may follow
one another to such a pitch that they evolve into a state of
generalized epilepsy. It is said that Jackson noted the attacks
that bear his name during his wife's confinement. She died
of sinus thrombosis after the childbirth. In some patients
with occlusion of the superior longitudinal sinus, edema of
the head and sometimes of the eyelids may be seen. Ex-
amination of the fundus of the eye may also show venous
dilation and peripapillary edema.
Thrombosis of the transverse sinus. This thrombosis
most often appears after purulent otitis media and mastoid-
itis. There are general inflammatory features (fever, leu-
kocytosis, increased blood sedimentation rate) and a painful
swelling behind the ear. The internal jugular vein is often
thickened and painful to the touch. Finally, symptoms re-
lated to the increased intracranial pressure may appear
(headaches. vomiting and papilledema).
Thrombosis of the sigmoid sinus. This thrombosis is
usually the result of mastoiditis. Here, too, general inflam-
matory features are seen with local edema at the posterior
border for the mastoid and sometimes signs of raised intra-
cranial pressure.
Thrombosis ofthe cavernous sinus. This develops after
inflammation of the upper lip or nose, sinusitis or maxillary
or dental infection. The clinical course is usually over-
whelming. During the first few days, unilateral symptoms
such as exophthalmus, pain or pressure on the eyeball, con-
junctival edema and symptoms due to damage to the com-
mon oculomotor, ophthalmic and external oculomotor nerves
are seen. Meningitis and abscess formation are not rare.
Thrombosis of the cerebral veins. This thrombosis may
be part of a "migrating thrombophlebitis," of an obliterative
thromboangiitis or of generalized infection. The patients
complain of headaches. which they have difficulty in lo-
calizing and which are probably due to meningeal irritation
or increased intracranial pressure. The cerebral features may
be secondary to edema, infarction of hemorrhage. They are
a function of the location of the thrombosis. The natural
course and prognosis are very variable. The outcome may
be fatal, but there is sometimes unexpected recovery. On
lumbar puncture, one often finds increased pressure in the
cerebral spinal fluid, which may be hemorrhagic. A definite
diagnosis may be possible only after cerebral angiography.
Treatment
Treatment is controversial. Some advise immediate an-
ticoagulation, while others prefer to use agents that decrease
cerebral edema (corticosteroids, mannitol) or even surgical
decompression. Anticonvulsant drugs are given in patients
with epileptic fits, and antibiotics are required whenever an
infectious origin of thrombosis is suspected. Some authors
have described hemorrhage after anticoagulant treatment,
which is predictable considering the hemorrhagic nature of
all venous cerebral infarcts. In our view, anticoagulation is
not to be recommended.
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Thrombosis of the Renal Vein
It is now more than 100 years since thrombosis of the
renal vein was first described, but for many decades it was
rarely diagnosed. During the last 20 years, the development
of improved angiographic techniques and early recognition
of the symptoms have increased the frequency with which
the diagnosis is made.
Pathogenesis
In the infant and young child, thrombosis of the renal
vein occurs as a complication of septicemia, diarrhea and
other states of dehydration (17). Infants of diabetic mothers
seem to be more susceptible to this complication (18). Renal
vein thrombosis has also been reported (19) as a possible
complication of angiocardiography in children with cyanotic
congenital heart disease.
Nephrotic syndrome. In the adult, the pathogenesis of
thrombosis of the renal vein is more complicatd. The as-
sociation with proteinuria was described as early as 1840
by Rayer (20). Initially, it was thought that the thrombosis
was the primary condition directly causing the nephrotic
syndrome and glomerular lesions through local venous hy-
pertension and associated hemodynamic disturbances in the
glomeruli. In recent years, the validity of this hypothesis
has been questioned by accumulating experimental and clin-
ical evidence suggesting a reverse etiologic relation. For
instance, experimentally induced renal vein thrombosis in
animals does not usually cause a nephrotic syndrome (21).
Patients whose renal veins are patent at the time of diagnosis
of a nephrotic syndrome, as shown by angiography, may
subsequently develop renal vein thrombosis (22). Moreover,
in cases of unilateral renal vein thrombosis, bilateral pro-
teinuria and bilateral histologic changes in the kidneys are
found. These are only some of the arguments frequently
cited that strongly favor the concept of a pre-existing renal
disorder (glomerulopathy) with a severe nephrotic syndrome
as the factor that predisposes to thrombosis of the renal vein
(and to other thromboembolic events).
Hypercoagulable state in nephrotic syndrome. Al-
though the exact pathogenic mechanism is not fully under-
stood, it is almost certain that it depends to a large degree
on the hypercoagulable state that accompanies the nephrotic
syndrome. Various anomalies have been described. First,
an increase in the number of platelets and in the concen-
tration of fibrinogen and other clotting factors (V, VIII and
X) as well as accelerated formation of factor Xa and in-
creased activation of factor XII have been noted (23). Re-
duced fibrinolysis has also been described and, recently,
convincing arguments have been advanced in favor of a
disturbance in platelet function (spontaneously increased
aggregation, raised levels of beta-thromboglobulin) (24). It
seems that the thromboembolic features associated with the
nephrotic syndrome relate best to plasma levels of anti-
thrombin III. In cases of the nephrotic syndrome, there may
be a significant loss of antithrombin III (molecular weight
65,000) in the urine (25). Its plasma level correlates closely
with the degree of proteinuria and level of hypoalbumin-
emia. A marked depression of antithrombin III concentra-
tion in blood can be expected in patients with a serum
albumin concentration below 20 g/Iiter (26). Reduction of
antithrombin III plasma activities to levels below 50% re-
sults in a definitely increased risk of venous thromboem-
bolism.
Renal vein thrombosis in membranous glomerulo-
nephritis. The incidence of renal vein thrombosis in the
nephrotic syndrome seems to be highest in patients with
membranous glomerulonephritis. According to a recent study
(27), the prevalence of renal vein thrombosis in the clinical
setting of membranous glomerulonephritis with nephrotic
syndrome is approximately 50% (including the broad range
from thrombotic occlusion of small peripheral renal veins
to unilateral or bilateral thrombosis of the main renal veins).
This is in accordance with the findings reported in an earlier
prospective study (28) of 48 patients with the nephrotic
syndrome. In this study, 5 of 9 patients with membranous
glomerulonephritis developed renal vein thrombosis, whereas
only 6 of 39 patients with other forms of glomerulonephritis
did. However, any of the other histologic forms of glo-
merulonephritis may be seen with this complication.
Predisposing factors in absence of glomerulopathy.
In the adult, thrombosis of the renal vein without pre-
existing glomerulopathy seems to be quite rare. Predispos-
ing factors include dehydration, venous congestion, states
of hypercoagulability (neoplasia, use of oral contraceptives
or corticosteroids) and local compression of the abdomen
or flanks (retroperitoneal fibrosis, abscess, tumor). Renal
parenchymal carcinoma and, less frequently, Wilms' tumors
or metastatic cancers may lead to thrombotic occlusion sec-
ondary to external compression or tumor extension along
the renal veins. Other conditions that have occasionally been
reported as initiating factors in renal vein thrombosis include
acute pancreatitis, trauma, abdominal or retroperitoneal op-
erations, sickle cell anemia, polyarteritis nodosa, systemic
lupus erythematosus, amyloidosis and diabetic glomerulo-
sclerosis.
Clinical Features and Diagnosis
Acute clinical presentations. In the irifant and young
child, thrombosis of the renal vein usually has an acute
character with a dramatic clinical picture. The most common
signs are gross hematuria, enlarged palpable kidneys and
thrombocytopenia (29). Fever, vomiting, cyanosis, leuko-
cytosis and mild proteinuria are often accompanied by signs
of renal failure; eventually, shock may occur.
In the adult, the clinical presentation of renal vein throm-
bosis varies according to the speed and degree of the venous
occlusion. A sudden occlusion may also generate an acute
and dramatic situation, with abdominal and lumbar pain and
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macroscopic hematuria. Clinical examination often reveals
a large kidney on palpation and a high blood pressure. There
are often signs of extrarenal thrombosis or pulmonary em-
bolism.
Clinical presentation. In the adult, renal vein throm-
bosis is generally of a chronic nature. After development
of a collateral venous circulation, the local symptoms are
often inconspicuous and the disorder is frequently missed.
There are, in fact, few or no characteristic disturbances, but
a series of phenomena which, isolated or taken together,
may arouse suspicion of this complication in patients with
the nephrotic syndrome. Undoubtedly, the first among these
are pulmonary emboli, which are often recurrent. Next,
where there is associated thrombosis of the inferior vena
cava, one should mention the appearance of edema out of
proportion with the degree of hypoalbuminemia or the ap-
pearance of a collateral circulation in the abdominal wall,
or both. Relatively sudden fluctuations in proteinuria or
renal function and proximal renal tubular disturbances may
be present, but they are less common. The serum level of
fibrin degradation products is raised. On intravenous py-
elography, acute unilateral thrombosis of the renal vein be-
trays its presence by asymmetric enlargement of the renal
outline and by stretching of the pelvis and calices (as in
polycystic kidneys), possibly with a much less clear cut
nephrogram. These phenomena, however, only last a few
weeks and may by followed by unilateral renal atrophy.
Ultimately, "notching" of the ureter by the imprint of the
collateral veins on the renal pelvis and proximal segment
of the ureter may appear, as it does in cases of thrombosis
that has developed gradually. This anomaly is somewhat
more specific, but it, too, is quite uncommon. In cases of
chronic thrombosis, the most usual finding is a morpholog-
ically normal outline.
Diagnostic methods. To confirm the diagnosis, one usu-
ally resorts to renal arteriography or retrograde venography
with direct selective catheterization of the main renal vein.
In the latter diagnostic procedure, concurrent epinephrine
injection into the renal artery facilitates the evaluation of
the small intrarenal veins by reducing blood flow.
It should be mentioned that phlebography is associated
with the risk of dislodging a thrombus that may precipitate
a pulmonary embolism. Therefore, among other available
techniques, high resolution ultrasonography may be helpful
in demonstrating the actual intravascular process in some
cases, while real time ultrasonography and Doppler studies
may be of diagnostic value by proving the absence of blood
flow. Most importantly, computed tomography is helpful in
detecting intraluminal thrombi in the large veins or tumor
extension to the renal vein.
Treatment
In generaL conservative management is to be preferred
to surgical intervention. In the acute phase, nephrectomy
or thrombectomy should be considered only in the rare cases
of bilateral renal vein thrombosis, which usually also in-
volves the inferior vena cava, and in cases of acute throm-
bosis of the renal vein associated with severe toxicity from
hemorrhagic infarction. Persistent hypertension, recurrent
infection of an atrophic kidney and unsuccessful medical
management, particularly in cases with recurrent pulmonary
embolism or renal failure, may necessitate an operation in
a later stage (29,30). Conservative management of renal
vein thrombosis involves correction of fluid and electrolyte
imbalance, antibiotic treatment of causative or complicating
infections and adequate therapy of underlying diseases and
complications such as shock and disseminated intravascular
coagulation.
Anticoagulant therapy. In patients with severe uremia,
early hemodialysis is required. Although anti-coagulant
treatment is still controversial in pediatric renal vein throm-
bosis, it is the therapy of choice in the adult (30). The
effectiveness of this treatment in prevention of local exten-
sion of thrombosis or new thromboembolism has been well
demonstrated. Thrombolytic agents have occasionally been
used with apparent success, but extended experience is still
lacking (31).
The Budd-Chiari Syndrome
The Budd-Chiari syndrome is a rare disorder character-
ized by hepatic venous outflow obstruction caused by partial
or complete thrombotic occlusion of the hepatic veins or
inferior vena cava or, as seen more often in the Far East,
by vena caval webs.
Pathogenesis
In 30 to 50% of the patients, the cause of the syndrome
remains unknown. Vena caval webs are a common cause
in the Orient and Japan. Certain hematologic disorders in-
cluding paroxysmal nocturnal hemoglobinuria, polycy-
themia vera and other myeloproliferative disorders have fre-
quently been reported as predisposing conditions (32,33).
Polycythemia may also occur secondary to the syndrome,
resulting from hemoconcentration and stimulation of the
bone marrow, probably as a result of increased production
of erythropoietin by the regenerating liver. It is now widely
accepted that there is a causal relation between the use of
oral contraceptives and hepatic vein thrombosis (32,34),
which would explain the greater frequency of the disorder
in young women. Intrahepatic and perihepatic tumors (in-
cluding hypernephroma) may also lead to the Budd-Chiari
syndrome. Beh<;et's disease (35) and antithrombin III de-
ficiency (36) have recently been identified as additional eti-
ologic factors.
Clinical Features
The clinical onset may be acute with abdominal pain,
marked ascites, hepatic failure and early death. Most often,
the disease begins more insidiously, and it is sometimes
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only after several weeks or months that the diagnosis be-
comes clear. The course and the severity of the symptoms
depend on the extent of the initial thrombotic process in the
hepatic veins and its possible associations with thrombosis
of the inferior vena cava. To the clinician, the association
of ascites, severe abdominal pain and enlargement of the
liver suggests this syndrome. The biochemical results are
not specific.
Diagnostic methods. Hepatic scintigraphy is the most
useful noninvasive technique of investigation, but ultraso-
nography and computed tomography may also furnish val-
uable information. Some rather small veins of the caudate
lobe of the liver drain directly into the vena cava. Concen-
tration of the isotope in this central territory is sufficiently
suggestive of the Budd-Chiari syndrome. Exact diagnosis
is established by venous angiography and liver biopsy.
Treatment
There is. as yet, no adequate treatment for the various
forms of the Budd-Chiari syndrome. In many cases, the
lethal outcome can be prevented only by establishment of
a portal-systemic shunt. Compression of the inferior vena
cava by the enlarged caudate lobe of the liver or thrombotic
occlusion of the inferior vena cava often precludes the cre-
ation of a portocaval anastomosis (37.38). In these cases,
a mesoatrial shunt may be an attractive alternative (39).
Peritoneovenous shunting by the Le Veen technique can be
useful for symptomatic relief of refractory ascites, but does
not correct the underlying abnormality (32).
Little is known about the usefulness ofthrombolytic ther-
apy in acute hepatic vein thrombosis. Oral anticoagulants
are given only to patients with incomplete occlusion of the
hepatic veins and are continued only if there is rapid im-
provement. Diuretic drugs are helpful in the management
of ascites, but do not affect the long-term outcome. In se-
lected cases, orthotopic liver transplantation (32,40) or per-
cutaneous transluminal angioplasty of the hepatic veins (41 )
should also be considered.
Thrombosis of the Portal Vein
Traditionally, it is in the child and adolescent that throm-
bosis of the portal vein has been described, but more recent
analysis has shown that more than half of the cases arise in
adults (42). Extension of the thrombosis to the splenic and
mesenteric veins is far from being exceptional.
Pathogenesis
In the child, infections are the most common etiologic
factor, whether they are abdominal or whether there is a
septicemia. particularly umbilical septicemia in the new-
born. Thrombosis of the portal vein has also been described
after catheterization of the umbilical vein.
In the adult, cirrhosis and hepatoma are the most frequent
causes. More than once, it has been possible to show pre-
liminary thrombophlebitis (including thrombophlebitis mi-
grans) with or without associated defiency of antithrombin
III. Patients with ulcerative colitis seem to be particularly
predisposed to thrombosis of the portal vein, but is not clear
if this is due to a state of hypercoagulability or to an infection
with portal bacteriemia (43). Other possible causes of throm-
bosis of the portal vein should be mentioned, especially
intraabdominal inflammatory processes (including appen-
dicitis. cholecystitis and pancreatic disease). Portal vein
thrombosis may also occur after surgery of the biliary tract
(44), after splenectomy in cases of hematologic disorders
or, but less often, in cases of abdominal trauma. Essential
thrombocytosis and polycythemia vera have also been re-
ported as predisposing conditions (44).
Congenital causes. In a considerable percentage of pa-
tients, particularly in children, no etiologic factor is found.
However, because of the frequent association of this syn-
drome with congenital anomalies, especially cardiovascular
ones, it is possible that congenital anomalies of the portal
vein may be a cause.
Clinical Features
Presentations. Usually, thrombosis of the portal vein
does not give rise to an acute and dramatic clinical picture.
Most often, portal hypertension is discovered together with
the complications that derive from it. Bleeding esophageal
varices or splenomegaly are common. especially in children.
The development of early and transitory ascites is a well
known complication of obstruction of the portal vein; it
disappears when the portal pressure decreases after devel-
opment of a collateral circulation. Chronic ascites is fairly
rare and has a poor prognosis, as does the presence of portal-
systemic encephalopathy. Consequences of portal hyper-
tension are vague dyspeptic symptoms such as flatulence,
anorexia, nausea and pains in the right hypochrondrium,
especially after meals.
Diagnostic methods. Lienoportal angiography or the
venous phase of angiography utilizing the splenic or superior
mesenteric artery have been the most useful diagnostic meth-
ods. At present, however, ultrasound and tomodensitometry
provide equally reliable diagnostic information (45,46).
Treatment
Surgical. Treatment, surgical or otherwise, of portal
vein thrombosis is still very controversial. The majority of
surgical operations are performed because of alimentary
bleeding; they involve the construction of one or the other
kind of portocaval shunt or a portocaval disconnection such
as section of the esophagus or resection of the stomach.
This surgical approach does not generally give satisfactory
results because it is often technically impossible to achieve
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adequate portocaval decompression. Another reason is the
poor state of the veins available for surgical anastomosis.
Nonsurgical. The state of health of patients with throm-
bosis of the portal vein may remain satisfactory for a long
period without recurrent alimentary bleeding. When bleed-
ing does occur, it is usually tolerated well, except in the
patient with cirrhosis and nonsurgical treatment is adequate.
In fact, because the natural history of portal hypertension
caused by thrombosis of the portal vein is often favorable
after a collateral venous circulation has developed, many
authors advise nonsurgical treatment. It must be mentioned
that as an exception to this rule, there are rare cases of
alimentary bleeding that cannot be controlled medically (44).
Whether long-term anticoagulation has a place in the therapy
of portal vein thrombosis is uncertain. The increased risk
of bleeding will probably outbalance the risk of further
thrombotic events in many patients.
Mesenteric Vein Thrombosis
Thrombosis of the mesenteric vein is less frequent than
occlusion of the mesenteric arteries.
Pathogenesis
Thrombosis of the mesenteric vein is usually secondary
to hematologic disorders such as polycythemia vera, hepatic
disorders with cirrhosis and portal hypertension, carcino-
matosis, inflammatory intraabdominal processes or acci-
dental or surgical trauma to the mesenteric veins. In about
25% of cases, thrombosis of the mesenteric vein is primary
or idiopathic in nature (47). However, there is often, it
seems, some predisposition to venous thrombosis. About
half of the patients have shown, sometimes years earlier,
thrombophlebitis, migratory or not, and usually in the legs.
Thrombosis of the mesenteric vein has also been described
in association with the use of estrogen-containing oral con-
traceptives (48), estrogen therapy for treatment of prostatic
carcinoma (49) and deficiency of antithrombin III (50) or
protein C (51). Apart from these latter cases, the syndrome
mostly affects old patients, and the thrombus is usually
situated in the superior mesenteric vein.
Cfinical Features
Presentation. The diagnosis is difficult and is usually
only made late because of the lack of objective signs; this
partly explains the high mortality associated with this syn-
drome. The clinical picture is distinctly less dramatic than
that of thrombosis of the mesenteric artery. Before the acute
phase begins, there is often a prodromal phase lasting from
several days to several weeks, characterized by variations
in the usual bowel habits and rather sudden progression into
intense abdominal pain with nausea. In other cases, progress
is less acute and there is a gradual deterioration of the
patient's general condition and abdominal pain develops
slowly. The prodromal phase depends on the location of the
initial thrombotic process and the extent of the collateral
circulation. Except in very advanced cases, the objective
signs are vague and do not contribute to making a firm
diagnosis. Abdominal distention and dehydration are com-
mon. Abdominal pain and muscular rigidity are variable.
The biochemical and radiologic findings are hardly specific.
Diagnostic methods. The most important diagnostic tests
are undoubtedly ultrasonography, which images the mes-
enteric vein, tomodensitometry and angiography with in-
jection of contrast medium into the superior mesenteric ar-
tery. With these techniques, it is possible in a substantial
number of cases to determine quite clearly if the vein is
patent. Paracentesis (aspiration of a malodorous serosan-
guineous fluid) and laparoscopy are other diasnostic meth-
ods.
Treatment
Laparotomy with resection of the threatened portion of
the intestine must be performed urgently. Without surgical
intervention mortality, is virtually 100% (52). In cases in
which the diagnosis is made very early or in which a more
central vein is also involved in the thrombotic process,
thrombectomy may be performed successfully. Because of
the predisposition to venous thrombosis and the risk of re-
currence even after successful surgical treatment, postop-
erative anticoagulant therapy is certainly indicated in the
idiopathic form. In patients with secondary mesenteric vein
thrombosis, the underlying disease (for example, cirrhosis,
carcinomatosis) often precludes the use of anticoagulants.
Some surgeons advise a "second look" intervention within
24 to 48 hours or at the slightest suspicion of recurrence.
Priapism
Priapism is a fairly rare disorder characterized by pro-
longed (often for several days) and usually painful penile
erection that is not necessarily related to sexual stimulation.
The syndrome is due to venous outflow obstruction from
the corpora cavemosa, either at the level of the deep dorsal
vein of the penis or, further distal to it, at the level of the
polsters, which have been postulated to control the diversion
of blood flow from the corpora into the venous system. In
contrast to natural erection, the corpus spongiosum is not
congested and the organ remains soft.
Etiology. So-called idiopathic priapism is often asso-
ciated with prolonged sexual excitement (53). Secondary
priapism has been described in a number of clinical settings
including hematologic disorder (such as sickle cell disease,
sickle cell trait, leukemia, polycythemia), metastatic car-
cinoma, local trauma or inflammation and neurologic dys-
function (such as spinal cord tumors, transverse myelitis
and tuberous sclerosis). A variety of drugs, especially psy-
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chotropic, antihypertensive and anticoagulant agents, have
been implicated in the etiology priapism. Alcohol and mar-
ijuana seem to be additional etiologic factors.
Nonsurgical treatment. Very prolonged priapism leads
to fibrosis of the septa of the corpora cavemosa, which
ultimately makes erection impossible. Thus, urgent medical
or surgical intervention to cause detumescence is required
within, at most, 72 hours after onset (54). A variety of
nonsurgical measures have been employed in the treatment
of priapism, including intravenous hydration. oxygenation,
sedation, analgesia, alkalinization, ice packs to the penis,
prostatic massage, cold or warm water enemas, or both,
and amyl nitrite (54,55). When results are inadequate, one
may resort to needle aspiration followed by irrigation of the
corpora cavemosa with saline solution. In cases of sickle
cell disease, exchange-transfusion is advised. In cases of
chronic myeloid leukemia, leukapheresis is suggested. Lo-
cal fibrinolytic therapy may be beneficial as adjunctive ther-
apy in the delayed treatment of priapism (56).
Surgical treatments. An initial period of approximately
12 hours of conservative management seems to be justifiable
in most cases (55). However, if conservative management
remains unsuccessful, prompt surgical intervention is man-
datory. Most commonly, the Winter procedure (57) is per-
formed, in which a glans-cavemous shunt is created by
means of a biopsy needle passed through the glans penis
and into the corpora cavemosa. On failure of this technique,
most investigators recommend the creation of a cavemosum-
spongiosum shunt.
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